John Maraganore - Insider Trading & Ownership

Location
75 Sidney St, Cambridge, MA
Summary
The estimated net worth of John Maraganore is at least $45M dollars as of June 26, 2025. John Maraganore is the Chief Executive Officer, Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $42.8M. John Maraganore is the Director of PROKIDNEY CORP. and owns shares of PROKIDNEY CORP. (PROK) stock worth about $921K. John Maraganore is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $741K. John Maraganore is the Director of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $564K.
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of John Maraganore

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALNY ALNYLAM PHARMACEUTICALS, INC. Chief Executive Officer, Director $42.8M Dec 21, 2021
PROK PROKIDNEY CORP. Director $921K Jun 29, 2023
AGIO AGIOS PHARMACEUTICALS, INC. Director $741K Dec 31, 2022
BEAM Beam Therapeutics Inc. Director $564K Jun 4, 2025
KYMR Kymera Therapeutics, Inc. Director Jun 25, 2025
RAPP Rapport Therapeutics, Inc. Director Jun 17, 2025

Insider Transactions Reported by John Maraganore:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.